G. Steven Burrill

Welcome from the CEO

Flash required to view this video. Download the latest version here

 G. Steven Burrill 

Podcast

On this edition of The Burrill Report, Bodenheimer, a professor at the Center for Excellence in Primary Care in the Department of Family and Community Medicine at the University of California, San Francisco, discusses why we must address the crisis in primary care for healthcare reform to succeed. 
Hear the podcast 
 
Sign up to receive email notifications about our upcoming events and news.


Sign up for a free subscription to The Burrill Weekly Brief 

Bryant E. Fong

Managing Director

Prior to joining Burrill & Company in 1998, Mr. Fong held positions as a biochemist and molecular biologist with two early-stage biotechnology companies located in the San Francisco Bay Area. His research experiences include recombinant protein expression in yeast, development of linear artificial chromosomes, and catalytic RNA technology.

Mr. Fong earned his bachelors degree with distinction and honors in Molecular and Cell Biology-Biochemistry from the University of California, Berkeley.

Mr. Fong currently serves on the Boards of Directors of FerroKin Biosciences, Nora Therapeutics, Neurotech Pharmaceuticals, Odyssey Thera, TRF Pharma, and Logical Therapeutics (observer).